sábado, 14 de septiembre de 2019

Many cancer drugs aim at the wrong molecular targets- Analysis using CRISPR gene-editing technology suggests that drugs’ mechanism of action are misunderstood. H Ledford, Nature, September 12, 2019

Main|Search|PHGKB

a hand holding a double helix


Last Posted: Sep 13, 2019


No hay comentarios:

Publicar un comentario